Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac Surgery
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16701 ↗At a glance
Multizentrische Studie in Journal of Cardiovascular Electrophysiology, 2025. Written by Gianluca Manzo and 14 co-authors. Institution: Presidio Ospedaliero Umberto I, Nocera Inferiore, Italy. Major MEDLINE topics: Pacemaker, Artificial, Arrhythmias, Cardiac, Cardiac Surgical Procedures, Cardiac Pacing, Artificial. Cited 1 times so far (Crossref); 20 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Micra leadless pacemaker offers an alternative to traditional transvenous pacemakers by eliminating the risks associated with leads and device pockets. Due to the technical demands of a leadless transcatheter pacemaker, concerns initially limited the procedure to centers with on‐site cardiac surgery (CS) capabilities. However, growing evidence supports its safe implementation in noncardiac surgical centers, though data comparing outcomes in these settings remain limited.
Aims
This analysis aims to evaluate the safety and feasibility of Micra leadless pacemaker implantation in centers with and without CS, assessing acute complications, device performance, and patient follow‐up.
Methods
A retrospective analysis was conducted on 1899 patients who received a Micra pacemaker from May 2015 to September 2024 at 23 centers. Patients were divided into two groups: those implanted in centers with CS (CS, n = 1025) and those without (No‐CS, n = 874). The primary endpoint was acute complications within 15 days postimplant, while secondary endpoints included device performance and clinical follow‐up at 12 months.
Results
The overall acute complication rate was low at 0.6%, with no significant difference between the CS (0.5%) and No‐CS groups (0.8%; p = 0.391). Procedural times were slightly shorter in No‐CS centers (41.2 ± 19.8 vs. 46.1 ± 19.3 min; p < 0.001), and both groups showed comparable device performance and patient outcomes over the follow‐up period.
Conclusion
The Micra leadless pacemaker can be safely and effectively implanted in centers without CS capabilities, broadening access to this technology across diverse clinical settings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Presidio Ospedaliero Umberto I, Nocera Inferiore, Italy.
- Fondazione Giglio, Cefalù, Italy.
- Azienda Ospedaliera dei Colli-Ospedale Monaldi, Napoli, Italy.
- Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
- Azienda Sanitaria Provinciale, Ospedale Giovanni Paolo II, Ragusa, Italy.
- Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.
ORCID profiles: Gianluca Manzo, Giulio Zucchelli, Pietro Palmisano, Sem Briongos, Saverio Iacopino
Funding
- The authors received no specific funding for this work.
Cite
APA
Manzo, G., Giannola, G., Nigro, G., Zucchelli, G., Nicosia, A., Palmisano, P., Bontempi, L., Viscusi, M., Liccardo, M., Piacenti, M., Coppola, G., Volpicelli, M., Morani, G., Briongos, S., & Iacopino, S. (2025). Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac Surgery. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16701
Vancouver
Manzo G, Giannola G, Nigro G, Zucchelli G, Nicosia A, Palmisano P, et al. Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac Surgery. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16701
BibTeX
@article{Manzo2025,
author = {Manzo, Gianluca and Giannola, Gabriele and Nigro, Gerardo and Zucchelli, Giulio and Nicosia, Antonino and Palmisano, Pietro and Bontempi, Luca and Viscusi, Miguel and Liccardo, Mattia and Piacenti, Marcello and Coppola, Giuseppe and Volpicelli, Mario and Morani, Giovanni and Briongos, Sem and Iacopino, Saverio},
title = {Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac Surgery},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16701}
}
EUVIMED